The usefulness of cube copying for evaluating treatment of Alzheimer's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 23, Issue 5, 2008, Pages 439-446

  Palmqvist, Sebastian ^a,b   Hansson, Oskar ^a   Minthon, Lennart ^a   Londos, Elisabet ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Box copying; Cholinesterase inhibitors; Cube copying; Necker cube; Treatment outcome

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL EVALUATION; CLINICAL GLOBAL IMPRESSION SCALE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CUBE COPYING; DEPTH PERCEPTION; DRAWING; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; SCORING SYSTEM; TASK PERFORMANCE; TECHNIQUE; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

EID: 54049121404     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317508320084     Document Type: Article

References (25)

1. National Institutes of Health. Progress Report on Alzheimer's Disease. Washington, DC: US Department of Health and Human Services ; 1999.
2. Scalco MZ, van Reekum R. Prevention of Alzheimer disease. Encouraging evidence. Can Fam Physician. 2006 ; 52: 200-207.
3. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006 ;(1):CD005593. doi:101002/14651858.
4. Emre M., Aarsland D., Albanese A.,, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med. 2004 ; 351: 2509-2518.
5. National Institute for Health and Clinical Excellence. Dementia: Supporting People With Dementia and Their Carers in Health and Social Care. London, UK: National Institute for Health and Clinical Excellence.
6. Graham N., Emery T., Hodges JR Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry. 2004 ; 75: 61-71.
7. Filley C., Kelly J., Heaton R. Neuropsychologic features of early- and late-onset Alzheimer's disease. Arch Neurol. 1986 ; 43: 574-576.
8. Binetti G., Cappa S., Magni E., Padovani A., Bianchetti A., Trabucchi M. Visual and spatial perception in the early phase of Alzheimer's disease. Neuropsychology. 1998 ; 12: 29-33.
9. Guerin F., Belleville S., Ska B. Characterization of visuoconstructional disabilities in patients with probable dementia of Alzheimer's type. J Clin Exp Neuropsychol. 2002 ; 24: 1-17.
10. Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Arch Neurol. 1991 ; 48: 73-77.
11. Kato M., Sano Y., Uno A. Constructive deficits in brain damaged patients: effects of the localized and /or diffuse cerebral lesions. Higher Brain Funct Res. 1988 ; 8: 305-319.
12. Maeshima S., Osawa A., Maeshima E., et al. Usefulness of a cube-copying test in outpatients with dementia. Brain Inj. 2004 ; 18: 889-898.
13. Maeshima S., Itakura T., Nakagawa M., Nakai K., Komai N. Visuospatial impairment and activities of daily living in patient's with Parkinson's disease: a quantitative assessment of the cube-copying task. Am J Phys Med Rehabil. 1997 ; 76: 383-388.
14. Ericsson K., Forssell L., Holmén K., Viitanen M., Winblad B. Copying and handwriting ability in the screening of cognitive dysfunction in old age. Arch Gerontol Geriatr. 1996 ; 22: 103-121.
15. Shimada Y., Meguro K., Kasai M., et al. Necker cube copying ability in normal elderly and Alzheimer's disease. A community-based study: the Tajiri project. Psychogeriatrics. 2006 ; 6: 4-9.
16. Wallin A., Andreasen N., Eriksson S., et al. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting. Dement Geriatr Cogn Disord. 2007 ; 23: 150-160.
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 ; 34: 939-944.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3 rd ed. rev. Washington DC: American Psychiatric Association ; 1987.
19. Rosen W., Mohs R., Davis K. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984 ; 141: 1356-1364.
20. Paganini-Hill A., Clark LJ Preliminary assessment of cognitive function in older adults by clock drawing, box copying and narrative writing. Dement Geriatr Cogn Disord. 2007 ; 23: 74-81.
21. Stomrud E., Hansson O., Blennow K., Minthon L., Londos E. Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly. Dement Geriatr Cogn Disord. 2007 ; 24: 118-124.
22. Folstein MF, Folstein SE, McHugh PF Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12: 182-198.
23. Green C., Mohs R., Schmeidler J., Aryan M., Davis K. Functional decline in Alzheimer's disease: a longitudinal study. J Am Geriatr Soc. 1993 ; 41: 654-661.
24. Schneider LS, Olin JT Clinical global impressions in Alzheimer's clinical trials. Int Psychogeriatr. 1996 ; 8: 277-290.
25. Han L., Cole M., Bellavance F., McCusker J., Primeau F. Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: a meta-analysis. Int Psychogeriatr. 2000 ; 12: 231-247.